Wedmont Private Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
GA
AP
MSV
SBWIC
NPPM
JC
MPWT
IWS
VC
CPBTD
Wedmont Private Capital's REGN Position: Q3 2026 in Review
Wedmont Private Capital increased its Regeneron Pharmaceuticals (REGN) stake by 6.9% in Q3 2026, buying an estimated $68K and bringing the position to 1,400 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #380.
Wedmont Private Capital first reported a position in REGN in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.57M in Q2 2024. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Wedmont Private Capital held 1,400 shares of Regeneron Pharmaceuticals worth $1.04M as of Q3 2026.
- Wedmont Private Capital bought 90 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $68K.
- Regeneron Pharmaceuticals made up 0.02% of Wedmont Private Capital's portfolio in Q3 2026, its #380 holding.
- Wedmont Private Capital first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- Wedmont Private Capital's Regeneron Pharmaceuticals position peaked at $1.57M in Q2 2024.
- 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.